Rhapsody

Curated by Signal

Developer of non-invasive device for cardiovascular disease detection

Overview

Developer of non-invasive device for cardiovascular disease detection. The company offers contactless AI-based system to analyze ECG data, providing detection of cardiovascular diseases.

Key facts

Founded: 2023
Headquarters: Stuttgart, Germany
Stage: Sign up to view
Industry: Life Sciences Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Medset Medizintechnik
Portfolio of devices and tools for cardio-pulmonary function diagnostics
Life Sciences TechnologyHamburg, Germany
ExCard Research
Centralized diagnostic ECG services
Life Sciences TechnologyHohen Neuendorf, Germany
Medipee
Developer of a device for urine analysis
Life Sciences TechnologyMoers, Germany

About Rhapsody

What does Rhapsody do?

Developer of non-invasive device for cardiovascular disease detection.

Where is Rhapsody headquartered?

Rhapsody is headquartered in Stuttgart, Germany.

When was Rhapsody founded?

Rhapsody was founded in 2023.

Which sector is Rhapsody in?

Rhapsody operates in Life Sciences Technology.

Who are Rhapsody's competitors?

Companies similar to Rhapsody include Medset Medizintechnik, ExCard Research, and Medipee.